Melinta Gets Nod For Ch. 11 Auction Starting At $140M
By Ryan Boysen · February 10, 2020, 3:20 PM EST
Ailing antibiotics developer Melinta Therapeutics Inc. appears to have secured approval for a previously contested Chapter 11 sale plan that allows top creditor Deerfield Management Co. to serve as the opening...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login